Hansen Medical, Inc.  

(Public, NASDAQ:HNSN)   Watch this stock  
Find more results for HNSN
-0.01 (-0.13%)
Jul 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.98 - 4.00
52 week 1.28 - 9.50
Open 3.99
Vol / Avg. 0.00/24,756.00
Mkt cap 75.77M
P/E     -
Div/yield     -
EPS -31.62
Shares 18.99M
Beta 0.37
Inst. own 32%
May 11, 2016
Hansen Medical Inc Annual Shareholders Meeting (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -317.95% -287.57%
Operating margin -261.31% -235.52%
EBITD margin - -219.55%
Return on average assets -96.52% -92.98%
Return on average equity - -1791.58%
Employees 130 -
CDP Score - -


800 East Middlefield Road
United States - Map
+1-650-4045800 (Phone)
+1-650-4045901 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Hansen Medical, Inc. is engaged in the development and marketing of medical devices. The Company develops, manufactures and sells a range of medical robotics designed for positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System (Sensei system), Artisan Extend Control Catheter, CoHesion 3D Visualization Module and Magellan System. Its Sensei system allows physicians to navigate catheters in interventional procedures within the atrial heart chambers. Its disposable Artisan Extend catheter assembly consists of a telescoping set of control catheters. Its CoHesion 3D Visualization Module is a software interface between its Sensei system and the St. Jude Medical EnSite System for Electro-Physiology procedures. The Magellan System controls the Magellan Robotic Catheter, which is a telescoping, steerable catheter designed to facilitate remote catheter navigation and vessel cannulation.

Officers and directors

Michael L. Eagle Lead Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Cary G. Vance President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Christopher P. Lowe Interim Chief Financial Officer, Director
Age: 48
Bio & Compensation  - Reuters
Robert O. Cathcart Senior Vice President - Global Sales
Age: 55
Bio & Compensation  - Reuters
Brian Sheahan Vice President - Clinical, Regulatory & Quality Affairs
Age: 49
Bio & Compensation  - Reuters
Marjorie L. Bowen Independent Director
Age: 50
Bio & Compensation  - Reuters
Kevin Hykes Independent Director
Age: 49
Bio & Compensation  - Reuters
Stephen Newman M.D. Independent Director
Age: 64
Bio & Compensation  - Reuters
William R. Rohn Independent Director
Age: 72
Bio & Compensation  - Reuters
Nadim Yared Independent Director
Age: 47
Bio & Compensation  - Reuters